References
- 1Ghosh D, Basu A. Japanese encephalitis-a pathological and clinical perspective. PLoS Negl Trop Dis. 2009; 3(9):
e437 . DOI: 10.1371/journal.pntd.0000437 - 2Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: A systematic review. Bull World Health Organ. 2011; 89(10): 766–774, 774A–774E. DOI: 10.2471/BLT.10.085233
- 3Ding D, Hong Z, Zhao SJ, et al. Long-term disability from acute childhood Japanese encephalitis in Shanghai, China. Am J Trop Med Hyg. 2007; 77(3): 528–533. DOI: 10.4269/ajtmh.2007.77.528
- 4Basumatary LJ, Raja D, Bhuyan D, Das M, Goswami M, Kayal AK. Clinical and radiological spectrum of Japanese encephalitis. J Neurol Sci. 2013; 325(1–2): 15–21. DOI: 10.1016/j.jns.2012.11.007
- 5Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2197–2223. DOI: 10.1016/S0140-6736(12)61689-4
- 6Lee WK, Lim D, Park H. Disability-Adjusted Life Years (DALYs) for Injuries Using Death Certificates and Hospital Discharge Survey by the Korean Burden of Disease Study 2012. Journal of Korean medical science. 2016; 31(Suppl 2): S200–s207. DOI: 10.3346/jkms.2016.31.S2.S200
- 7Tarantola A, Goutard F, Newton P, et al. Estimating the burden of Japanese encephalitis virus and other encephalitides in countries of the mekong region. PLoS Negl Trop Dis. 2014; 8(1):
e2533 . DOI: 10.1371/journal.pntd.0002533 - 8Labeaud AD, Bashir F, King CH. Measuring the burden of arboviral diseases: the spectrum of morbidity and mortality from four prevalent infections. Popul Health Metr. 2011; 9(1): 1. DOI: 10.1186/1478-7954-9-1
- 9World Health Organization (WHO). Japanese Encephalitis Vaccines: WHO position paper, February 2015—Recommendations. Vaccine. 2016; 34(3): 302–303. DOI: 10.1016/j.vaccine.2015.07.057
- 10Lee EJ, Cha GW, Ju YR, Han MG, Lee WJ, Jeong YE. Prevalence of Neutralizing Antibodies to Japanese Encephalitis Virus among High-Risk Age Groups in South Korea, 2010. PloS one. 2016; 11(1):
e0147841 . DOI: 10.1371/journal.pone.0147841 - 11Hsu LC, Chen YJ, Hsu FK, et al. The incidence of Japanese encephalitis in Taiwan—a population-based study. PLoS Negl Trop Dis. 2014; 8(7):
e3030 . DOI: 10.1371/journal.pntd.0003030 - 12Gao X, Li X, Li M, et al. Vaccine strategies for the control and prevention of Japanese encephalitis in Mainland China, 1951–2011. PLoS Negl Trop Dis. 2014; 8(8):
e3015 . DOI: 10.1371/journal.pntd.0003015 - 13Ren X, Fu S, Dai P, et al. Pigsties near dwellings as a potential risk factor for the prevalence of Japanese encephalitis virus in adult in Shanxi, China. Infectious diseases of poverty. 2017; 6(1): 100. DOI: 10.1186/s40249-017-0312-4
- 14Li X, Cui S, Gao X, et al. The Spatio-temporal Distribution of Japanese Encephalitis Cases in Different Age Groups in Mainland China, 2004–2014. PLoS Negl Trop Dis. 2016; 10(4):
e0004611 . DOI: 10.1371/journal.pntd.0004611 - 15Guo L, Bai G, Zhang H, Lu D, Zheng J, Xu G. Cognitive Functioning in Temporal Lobe Epilepsy: A BOLD-fMRI Study. Molecular neurobiology. 2017; 54(10): 8361–8369. DOI: 10.1007/s12035-016-0298-0
- 16Margolis A, Bansal R, Hao X, et al. Using IQ discrepancy scores to examine the neural correlates of specific cognitive abilities. The Journal of neuroscience: The official journal of the Society for Neuroscience. 2013; 33(35): 14135–14145. DOI: 10.1523/JNEUROSCI.0775-13.2013
- 17de Montferrand C, Vassel-Hitier J, Yvon-Chaou E, Câmara-Costa H, Dellatolas G, Chevignard M. Language and cognitive outcomes after childhood stroke: Theoretical implications for hemispheric specialization. Cortex; A journal devoted to the study of the nervous system and behavior. 2019; 120: 509–523. DOI: 10.1016/j.cortex.2019.07.020
- 18Shurtleff H, Barry D, Chanprasert S, Firman T, Warner M, Saneto RP. Cognitive characteristics of mitochondrial diseases in children. Epilepsy & behavior: E&B. 2018; 88: 235–243. DOI: 10.1016/j.yebeh.2018.09.013
- 19Chatham CH, Taylor KI, Charman T, et al. Adaptive behavior in autism: Minimal clinically important differences on the Vineland-II. Autism research: official journal of the International Society for Autism Research. 2018; 11(2): 270–283. DOI: 10.1002/aur.1874
- 20Brusse E, Brusse-Keizer MG, Duivenvoorden HJ, van Swieten JC. Fatigue in spinocerebellar ataxia: Patient self-assessment of an early and disabling symptom. Neurology. 2011; 76(11): 953–959. DOI: 10.1212/WNL.0b013e31821043a4
- 21Janković S, Vlajinac H, Bjegović V, et al.
The Burden of Disease and Injury in Serbia . In: Preedy VR, Watson RR (eds.), Handbook of Disease Burdens and Quality of Life Measures. 2010; 587–601. New York, NY: Springer New York. DOI: 10.1007/978-0-387-78665-0_34 - 22WHO. Global Burden of Disease 2004 Update: Disability Weights for diseases and conditions.
http://www.who.int/healthinfo/global_burden_disease/GBD2004_DisabilityWeights.pdf [accessed 8 Oct 2021]. - 23Murray CJ. Quantifying the burden of disease: The technical basis for disability-adjusted life years. Bull World Health Organ. 1994; 72(3): 429–445.
- 24Lewthwaite P, Begum A, Ooi MH, et al. Disability after encephalitis: Development and validation of a new outcome score. Bull World Health Organ. 2010; 88(8): 584–592. DOI: 10.2471/BLT.09.071357
- 25Schneider RJ, Firestone MH, Edelman R, Chieowanich P, Pornpibul R. Clinical sequelae after japanese encephalitis: A one year follow-up study in Thailand. Southeast Asian J Trop Med Public Health. 1974; 5(4): 560–568.
- 26Ooi MH, Lewthwaite P, Lai BF, et al. The epidemiology, clinical features, and long-term prognosis of Japanese encephalitis in central sarawak, malaysia, 1997–2005. Clin Infect Dis. 2008; 47(4): 458–468. DOI: 10.1086/590008
- 27Yin Z, Wang X, Li L, et al. Neurological sequelae of hospitalized Japanese encephalitis cases in Gansu province, China. Am J Trop Med Hyg. 2015; 92(6): 1125–1129. DOI: 10.4269/ajtmh.14-0148
- 28Huy BV, Tu HC, Luan TV, Lindqvist R. Early mental and neurological sequelae after Japanese B encephalitis. Southeast Asian J Trop Med Public Health. 1994; 25(3): 549–553.
- 29Kamala CS, Rao MV, George S, Prasanna NY. Japanese encephalitis in children in Bellary Karnataka. Indian Pediatr. 1989; 26(5): 445–452.
- 30Sarkari NB, Thacker AK, Barthwal SP, et al. Japanese encephalitis (JE) part II: 14 years’ follow-up of survivors. J Neurol. 2012; 259(1): 58–69. DOI: 10.1007/s00415-011-6131-9
- 31Chen HL, Chang JK, Tang RB. Current recommendations for the Japanese encephalitis vaccine. J Chin Med Assoc. 2015; 78(5): 271–275. DOI: 10.1016/j.jcma.2014.12.009
- 32Yun SI, Lee YM. Japanese encephalitis: the virus and vaccines. Human vaccines & immunotherapeutics. 2014; 10(2): 263–279. DOI: 10.4161/hv.26902
- 33Zhang H, Wang Y, Li K, Mehmood K, Gui R, Li J. Epidemiology of Japanese Encephalitis in China (2004–2015). Travel Med Infect Dis. 2019; 28: 109–110. DOI: 10.1016/j.tmaid.2018.09.011
- 34Yin Z, Wang H, Yang J, et al. Japanese encephalitis disease burden and clinical features of Japanese encephalitis in four cities in the People’s Republic of China. Am J Trop Med Hyg. 2010; 83(4): 766–773. DOI: 10.4269/ajtmh.2010.09-0748